Can Blood Work Detect Seizures?

No single blood test can definitively confirm that a seizure has occurred, but several markers in the blood shift measurably after certain types of seizures, and clinicians routinely use these changes as supporting evidence. The most useful markers, like prolactin and lactate, work best after convulsive seizures and within narrow time windows. The picture gets more complicated with non-convulsive or focal seizures, where blood values may barely budge. Beyond detecting that a seizure happened, blood work plays a separate and equally important role in figuring out why it happened in the first place.

Prolactin Is the Best-Studied Blood Marker

Prolactin, a hormone released by the pituitary gland, has been studied for decades as a seizure biomarker. After a generalized tonic-clonic seizure (the kind with full-body convulsions), prolactin levels in the blood typically spike within 10 to 20 minutes and return to baseline within about an hour. The American Academy of Neurology reviewed the evidence and found that elevated serum prolactin was highly predictive of either generalized tonic-clonic or complex partial seizures when used to distinguish them from psychogenic nonepileptic seizures. The pooled sensitivity was about 60% for tonic-clonic seizures and about 46% for complex partial seizures, while specificity was approximately 96% for both types.¹ That high specificity means a genuinely elevated prolactin after a witnessed event strongly suggests a real epileptic seizure rather than a psychogenic episode. But the moderate sensitivity means prolactin stays normal after a substantial portion of real seizures, so a normal result does not rule one out.

An emergency-department study confirmed this pattern and found that prolactin performed well when distinguishing psychogenic nonepileptic seizures from epileptic events, both with and without convulsions. For convulsive events, a prolactin cutoff of about 40 ng/mL yielded roughly 91% sensitivity and 68% specificity in separating psychogenic episodes from epileptic ones. For non-convulsive events, a lower cutoff of 24 ng/mL pushed sensitivity to 100% and specificity to about 83%.² The catch is timing: prolactin needs to be drawn within the first hour after the event. Wait much longer and the spike will have faded, leaving you with a useless result.

Lactate Spikes Are Quick and Dramatic

When someone has a tonic-clonic seizure, the violent muscle contractions burn through oxygen faster than the body can supply it, producing a surge of lactate. Blood lactate levels jump almost immediately after convulsive seizures, reflecting that burst of anaerobic muscle activity.³ In one study of patients who had seizures during inpatient monitoring, lactate rose roughly ninefold immediately after tonic-clonic seizures and took about two hours to drift back toward normal. Nearly 90% of tonic-clonic seizures pushed lactate above twice the upper limit of normal, and the longer the convulsive phase lasted, the higher the lactate climbed.⁴

Lactate has a practical advantage over prolactin: it is part of standard emergency blood panels and can be run on point-of-care devices in minutes. It is also useful in prehospital settings, where paramedics may draw blood shortly after a convulsion. The downside is that lactate is not specific to seizures. A person who fainted and hit the ground, someone having a panic attack with hyperventilation, or anyone who just ran up a flight of stairs can have elevated lactate for entirely different reasons. Lactate is most helpful when combined with other markers and clinical context rather than interpreted alone.

Creatine Kinase Tells a Slower Story

Creatine kinase, or CK, is an enzyme released when muscle tissue is damaged or overworked. Because tonic-clonic seizures involve intense, uncontrolled muscle contractions, CK levels often rise afterward. The time course is different from prolactin or lactate: CK typically begins to climb in the first 1 to 12 hours and peaks somewhere between 24 and 72 hours after a convulsive seizure.⁵ That delayed peak makes CK useful when a patient shows up in the emergency department hours after a suspected seizure and the prolactin window has already closed.

A retrospective study and meta-analysis covering over 1,300 patients found CK levels were significantly higher 48 hours after an epileptic seizure compared to patients who had syncope, and the pooled data from multiple studies showed a large mean difference between epileptic seizures and psychogenic events.⁶ CK is not perfect either. It rises after falls, intense exercise, intramuscular injections, and many other causes of muscle strain. But in a patient found unresponsive with no clear history, a markedly elevated CK 24 hours later is a strong clue that convulsions occurred.

Combining Markers Improves Accuracy

No single blood marker is accurate enough to serve as a standalone seizure test. Researchers have found that combining multiple markers into a panel dramatically improves diagnostic performance. One study looking at neuron-specific enolase (NSE), CK, and lactate dehydrogenase (LDH) found that NSE alone had over 93% sensitivity and nearly 96% specificity for distinguishing seizures from syncope in emergency patients.⁷

A more recent prospective study took a different approach, building a combined model using phosphate, lactate, prolactin, and ammonia levels drawn after events. The four-marker panel achieved excellent diagnostic performance in separating epileptic seizures from both functional seizures and syncope.⁸ Ammonia, which rises after tonic-clonic seizures due to intense muscle metabolism, adds diagnostic power that prolactin or lactate alone cannot provide. The trend in the research is clearly moving toward multimarker panels rather than relying on any one test.

Cortisol and the Stress Response

An epileptic seizure triggers a powerful stress response. Cortisol, the body’s main stress hormone, rises sharply within the first hour after an epileptic seizure but does not increase after psychogenic nonepileptic seizures.⁹ This difference makes cortisol potentially useful for the same purpose as prolactin: telling apart real seizures from psychogenic episodes. It shares the same timing limitation, though. The cortisol spike is transient, and blood needs to be drawn soon after the event.

The Timing Problem

Every seizure biomarker has its own clock. Prolactin peaks within about 20 minutes and fades within an hour. Lactate peaks immediately and normalizes within two hours. CK rises slowly over hours and peaks at one to three days. Cortisol spikes within the first hour. If blood is drawn outside these windows, the results can look completely normal even if a seizure clearly happened. This is one of the biggest practical limitations of using blood work to detect seizures: emergency departments are busy, patients may not arrive for hours, and nobody may think to draw the right tests at the right time.

Reviewing the evidence broadly, researchers have concluded that presently no postictal lab values can definitively prove or rule out an epileptic seizure.¹⁰ Blood markers are best understood as supporting evidence. They help when combined with witness accounts, EEG findings, and clinical history. They are not a replacement for any of those.

Focal and Non-Convulsive Seizures Are Much Harder to Detect

Almost all of the blood markers discussed above work best for tonic-clonic seizures, the kind involving full-body convulsions and intense muscle activity. Focal seizures, absence seizures, and other non-convulsive types produce much smaller or no detectable changes in the blood. Prolactin may rise modestly after complex partial seizures but rarely changes after simple partial seizures. CK generally stays flat because the muscles are not overworked. Lactate does not spike without significant convulsive activity.

Inflammatory markers like interleukin-6 (IL-6) show a similar pattern. IL-6 in plasma increased significantly within 24 hours after generalized tonic-clonic seizures and febrile seizures, but did not change after complex partial seizures in patients with chronic epilepsy. Only patients with temporal lobe epilepsy who had secondary generalized seizures showed a notable rise in IL-6.¹¹ For the large number of people whose seizures are focal or non-convulsive, blood work is essentially blind to the event itself.

Blood Tests to Find the Cause of Seizures

Separate from detecting whether a seizure happened, blood work is essential for figuring out why it happened. A first-time seizure in an adult triggers a workup that includes basic metabolic panels. Low sodium, low calcium, low magnesium, very low or very high blood sugar, kidney failure, and liver failure can all provoke seizures. Identifying these metabolic triggers through standard blood tests is straightforward and critical, because treating the underlying cause may be the only treatment needed.¹⁰ Toxic exposures, alcohol withdrawal, and infections can also cause seizures and often leave detectable traces in routine labs.

A less common but increasingly recognized cause is autoimmune encephalitis, where the immune system produces antibodies that attack brain proteins and trigger seizures. In a prospective study of adults with new-onset seizures, about 4.5% tested positive for clinically significant neuronal antibodies, including antibodies against CASPR-2 and GAD.¹² One of those patients turned out to have an undiagnosed cancer that was driving the antibody production. Autoimmune antibody panels are not routine for every seizure patient, but clinicians order them when the clinical picture is unusual, when MRI shows inflammation, or when standard treatments fail to control the seizures. These blood tests do not detect the seizure itself; they detect the underlying disease that is causing the seizures.

Monitoring Anti-Seizure Medication Levels

For people already diagnosed with epilepsy, one of the most common reasons for blood draws is therapeutic drug monitoring. Many anti-seizure medications have a narrow range where they are effective but not toxic, and a simple blood test measures the drug’s concentration to check whether it falls within that range. This matters in several scenarios: when seizures break through despite treatment, when side effects suggest the dose may be too high, during pregnancy when drug metabolism changes, and when a clinician suspects the patient is not taking the medication consistently.

One real-world study found that among patients suspected of poor medication compliance, a majority had drug levels below the therapeutic range. After counseling focused on adherence, nearly three-quarters of those patients experienced fewer seizures, and about half became seizure-free.¹³ Drug level testing is routine, inexpensive, and can be the difference between labeling someone as having drug-resistant epilepsy and discovering they simply were not absorbing enough medication.

Neurofilament Light Chain and Seizure-Related Brain Injury

Emerging research has focused on markers that reflect actual neuronal damage rather than just the metabolic aftermath of convulsions. Neurofilament light chain (NfL) is a structural protein released into the blood when nerve fibers are injured. In one study, patients with status epilepticus (a prolonged seizure emergency) had blood NfL levels roughly three to four times higher than patients with drug-resistant epilepsy or healthy controls. Higher NfL levels correlated with longer seizure duration, treatment resistance, and worse outcomes, including a tenfold increase in the odds of clinical worsening or death within 30 days when levels exceeded about 29 pg/mL.¹⁴

A separate study confirmed the pattern and found that NfL levels were significantly higher after status epilepticus than after a single seizure or a cluster of seizures, with a moderate positive correlation between seizure duration and NfL concentration.¹⁵ NfL is not yet a routine clinical test for seizures, but it is increasingly available on commercial lab platforms and may eventually help clinicians gauge how much neuronal damage a prolonged seizure has caused. For ordinary self-limiting seizures, NfL levels tend to stay much lower and may not rise above normal at all.

Blood-Brain Barrier Markers After Seizures

Seizures can transiently increase the permeability of the blood-brain barrier, the protective layer that normally keeps most blood-borne substances out of the brain. Researchers measured several markers of barrier integrity after bilateral tonic-clonic seizures and found increased levels of S100B, ICAM-1, MMP-9, and P-selectin at 1 to 3 hours and again at 24 hours. Markers associated with barrier repair, such as TIMP-1 and thrombomodulin, rose later, at 24 and 72 hours.¹⁶ These findings suggest a sequence where the barrier opens during and shortly after the seizure, and the body then mounts a repair response over the following days. This matters because barrier disruption may feed back into further seizure susceptibility, potentially contributing to a cycle in some patients. These markers are research tools right now, not bedside tests, but they illustrate how blood work is gradually revealing more about what seizures do to the brain.

Pediatric Seizures and Febrile Events

Children present unique considerations. Febrile seizures, which occur in young children during high fevers, are the most common type of seizure in pediatrics. Standard blood markers like prolactin and CK have been less thoroughly studied in young children, and the clinical question is usually different: the priority is figuring out whether the fever is caused by something dangerous like meningitis, not confirming the seizure itself.

Research on S100B, a protein sometimes used as a marker of brain injury, found no significant difference in blood levels between children who had simple febrile seizures and control groups, suggesting that uncomplicated febrile seizures do not cause measurable neuronal damage detectable by this marker.¹⁷ That is actually reassuring for parents: a simple febrile seizure, while frightening to witness, does not appear to injure the brain in a way that spills detectable proteins into the blood.

Inflammatory markers show more activity. Pro-inflammatory cytokines including IL-1β, IL-6, and TNF-α have been found to be significantly elevated in children with febrile seizures. Researchers have also explored inexpensive markers from a standard complete blood count, such as the neutrophil-to-lymphocyte ratio and mean platelet volume, as potential indicators of febrile seizure risk. These are far from validated diagnostic tools, but they hint at an inflammatory profile that might eventually help identify which febrile children are more likely to seize.

MicroRNAs and the Future of Seizure Blood Testing

One of the more speculative frontiers involves circulating microRNAs, tiny fragments of genetic material that regulate gene expression and can be detected in blood. A research group has proposed several microRNAs as potential biomarkers, including miR-671 and miR-9a-3p as markers of epilepsy itself, and miR-206-5p as a marker of epileptogenesis, meaning the process by which the brain becomes prone to seizures before any seizure has occurred.¹⁸ If validated, a blood test that detects epileptogenesis could theoretically identify people at risk of developing epilepsy after a brain injury or stroke, before they ever have a seizure. That remains a long way from clinical use, but it represents a fundamentally different goal from the current markers: predicting seizures rather than confirming them after the fact.